Amp Capital Investors LTD Novavax Inc Transaction History

Amp Capital Investors LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$134.56 - $217.97 $1.86 Million - $3.01 Million	-13,788 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$177.8 - $270.58 $189,357 - $288,167	-1,065 Reduced 7.17%	13,788 $2.86 Million
Q2 2021 Aug 16, 2021	BUY	$121.0 - $257.67 $1.8 Million - $3.83 Million	14,853 New	14,853 $3.15 Million
Q1 2021 May 17, 2021	SELL	$112.98 - $319.93 $830,290 - $2.35 Million	-7,349 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$78.74 - $139.5 $31,259 - $55,381	397 Added 5.71%	7,349 $874,000
Q3 2020 Nov 12, 2020	BUY	$79.44 - $178.51 $552,266 - $1.24 Million	6,952 New	6,952 $750,000

290

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $662M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Amp Capital Investors LTD, based on Form 13F filings with the SEC.

Stay updated on Amp Capital Investors LTD with notifications on news.